Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Early microvascular coronary endothelial dysfunction precedes pembrolizumab-induced cardiotoxicity. Preventive role of high dose of atorvastatin
Panagiotis Efentakis, Angeliki Choustoulaki, Grzegorz Kwiatkowski, Aimilia Varela, Ioannis V. Kostopoulos, George Tsekenis, Ioannis Ntanasis‐Stathopoulos, Anastasios D. Georgoulis, Constantinos E. Vorgias, Harikleia Gakiopoulou, Αlexandros Briasoulis, Constantinos H. Davos, Nikolaos Kostomitsopoulos, Ourania Tsitsilonis, Meletios A Dimopoulos, Evangelos Terpos, Stefan Chłopicki, Maria Gavriatopoulou, Ioanna Andreadou (2024). Early microvascular coronary endothelial dysfunction precedes pembrolizumab-induced cardiotoxicity. Preventive role of high dose of atorvastatin. , 120(1), DOI: https://doi.org/10.1007/s00395-024-01046-0.
Article25 days agoImplications and hidden toxicity of cardiometabolic syndrome and early‐stage heart failure in carfilzomib‐induced cardiotoxicity
Panagiotis Efentakis, Aimilia Varela, Sofia Lamprou, Eleni‐Dimitra Papanagnou, Michail Chatzistefanou, Andriana Christodoulou, Constantinos H. Davos, Maria Gavriatopoulou, Ioannis P. Trougakos, Meletios A Dimopoulos, Evangelos Terpos, Ioanna Andreadou (2024). Implications and hidden toxicity of cardiometabolic syndrome and early‐stage heart failure in carfilzomib‐induced cardiotoxicity. , 181(16), DOI: https://doi.org/10.1111/bph.16391.
Article25 days agoImplications and hidden toxicity of cardiometabolic syndrome and early‐stage heart failure in carfilzomib‐induced cardiotoxicity
Panagiotis Efentakis, Aimilia Varela, Sofia Lamprou, Eleni‐Dimitra Papanagnou, Michail Chatzistefanou, Andriana Christodoulou, Constantinos H. Davos, Maria Gavriatopoulou, Ioannis P. Trougakos, Meletios A Dimopoulos, Evangelos Terpos, Ioanna Andreadou (2024). Implications and hidden toxicity of cardiometabolic syndrome and early‐stage heart failure in carfilzomib‐induced cardiotoxicity. , 181(16), DOI: https://doi.org/10.1111/bph.16391.
Article25 days agoEstablishment of an in vivo murine model of immune checkPoint inhibitors cardiotoxicity: emerging role of vascular permeability in pembrolizumab-induced cardiotoxicity
Panagiotis Efentakis, Angelina Choustoulaki, Ioannis V. Kostopoulos, Aimilia Varela, Anastasios D. Georgoulis, George Tsekenis, Charikleia Gakiopoulou, Ioannis Ntanasis‐Stathopoulos, Constantinos H. Davos, O.E. Tsitsiloni, Meletios A Dimopoulos, Evangelos Terpos, Maria Gavriatopoulou, Ioanna Andreadou (2023). Establishment of an in vivo murine model of immune checkPoint inhibitors cardiotoxicity: emerging role of vascular permeability in pembrolizumab-induced cardiotoxicity. , 44(Supplement_2), DOI: https://doi.org/10.1093/eurheartj/ehad655.770.
Article25 days agoP-254 Cardiac and hidden toxicity of carfilzomib in presence of cardiometabolic syndrome and early-stage heart failure with reduced ejection fraction
Panagiotis Efentakis, Aimilia Varela, Sofia Lamprou, Eleni‐Dimitra Papanagnou, Michail Chatzistefanou, Andriana Christodoulou, Constantinos H. Davos, Maria Gavriatopoulou, Ioannis P. Trougakos, Meletios A Dimopoulos, Ioanna Andreadou, Evangelos Terpos (2023). P-254 Cardiac and hidden toxicity of carfilzomib in presence of cardiometabolic syndrome and early-stage heart failure with reduced ejection fraction. , 23, DOI: https://doi.org/10.1016/s2152-2650(23)01872-4.
Article25 days ago